Navigation Links
SensoTech Awarded Wireless Temperature Monitoring Contract By Amerinet
Date:6/25/2009

SensoTech Inc, a market leader in Environmental Monitoring solutions for the Healthcare Industry, announced that its RFID Wireless Temperature monitoring and other environmental monitoring solutions, are now available to more than 2,300 Amerinet healthcare customers.

Simi Valley, CA (PRWEB) June 25, 2009 -- SensoTech Inc, a market leader in Environmental Monitoring solutions for the Healthcare Industry, announced that its RFID Wireless Temperature monitoring and other environmental monitoring solutions, are now available to more than 2,300 Amerinet healthcare customers.

SensoTech Inc. is the only solution provider to offer wireless digital temperature sensors with integrated and advanced firmware which includes web server, and database. Non volatile programs are embedded in the chip and devices instead of external software, databases, or web servers. To the organizations it means zero software installation, no database or web server maintenance, no outside hosting, and no hidden costs.

Designed and manufactured in Sweden, the patented and breakthrough technology has been utilized by European medical, pharmaceutical, food, and other industries since 2004. Since its recent introduction to the US market, many of the "Best Hospitals" have chosen SensoTech as their Enterprise Monitoring Solution.

Mike Zarei Vice president of Business Development, commented, "We are very pleased to be working with AmeriNet to provide its members and affiliate our RFID wireless temperature and other environmental monitoring solutions. SensoTech offers a unique and cost effective solution to help hospitals, remote clinics, pharmacies, laboratories, blood banks, nutrition services and Vaccine centers to meet joint commission, AABB, CAPS and other regulatory health requirements."

Amerinet is one of the nation's largest and most respected group purchasing organizations and has set the standard for integrity and customer service for more than two decades promoting quality healthcare delivery and helping healthcare providers more cost effectively managed expenses.

About SensoTech:
SensoTech is a market leader in environmental monitoring solutions for the healthcare industry. SensoTech provides wireless environmental monitoring systems for applications where it may be mission critical to monitor and respond to instant environmental changes. The SensoTech zero-cost infrastructure model eliminates the need for computer hardware, network servers and software, and reduces costs in technology ownership.Sensotech is headquartered in Simi Valley, CA for more information, call 800-279-3101 or visit www.sensotechnologies.com

###

Read the full story at http://www.prweb.com/releases/2009/06/prweb2570874.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved

Related medicine news :

1. Saving Vaccines with SensoTech's Breakthrough in Vaccine Temperature Monitoring
2. Peregrine Pharmaceuticals Awarded Broad New U.S. Patent for Vascular Imaging Applications of Its PS-Targeting Platform
3. Bumrungrad International the first private hospital to be awarded Thailand Quality Class (TQC) for organizational excellence
4. ANSi Answers When Awarded the Philadelphia Business Journals Prestigious 2009 South Jersey 25 Accolade
5. Family Care Awarded First Multiple Product Discount Medical Plan License in California
6. MUHC researcher awarded $500,000 to study pathogenesis of infectious disease
7. Social Security Disability Benefits Awarded Disparately Across the US Reports www.social-security-lawyers.net
8. Massachusetts Health Quality Partners Awarded Consulting Contract for State Quality and Cost Reporting Initiative
9. J. Craig Venter Institute Awarded $43 Million, Five Year Contract From NIAID to Continue to Develop and Provide Sequencing, Genotyping, and Bioinformatics Expertise and Services in Infectious Diseases
10. Acclarent, Inc. Awarded Red Herring 100 North America
11. Concurrent Technologies Corporation Awarded Contract to Support the Centers for Disease Control and Prevention with Readiness Efforts
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/21/2017)... ... July 21, 2017 , ... ... students improve their chances of acceptance to a residency in a United States ... earned degrees outside the U.S. , According to data released by the ECFMG®, ...
(Date:7/21/2017)... ... July 21, 2017 , ... West Dermatology is pleased ... Vu, PA-C. Beginning July 17, 2017, Ms. Vu will join West Dermatology’s large network ... experience in dermatology, skin cancer , and more. She graduated from the University ...
(Date:7/21/2017)... ... July 21, 2017 , ... How physicians and ... the rise, say researchers presenting their work at the American Orthopaedic Society ... combination of evaluating the patterns of change in concussion symptom presentation, diagnostic tools ...
(Date:7/20/2017)... ... July 20, 2017 , ... Acute myeloid leukemia (AML) is ... rapidly without treatment. Newly diagnosed patients face intense chemotherapy regimens and a stem ... With such a challenging diagnosis that requires immediate action, patients and caregivers ...
(Date:7/20/2017)... ... ... For individuals with extended hospital stays or who are residents of nursing ... specially designed to accommodate patients with a wide range of ailments or special needs, ... has invented the patent-pending PORTABLE ARM REST, a specially designed armrest that features many ...
Breaking Medicine News(10 mins):
(Date:7/12/2017)... and Company (NYSE: LLY ) has entered into ... litigation in the U.S. District Court for the Eastern District ... (tadalafil) unit dose patent. This patent was previously set ... agreement, Cialis exclusivity is now expected to end at the ... patent for Cialis is valid and infringed by companies seeking ...
(Date:7/11/2017)... 11, 2017  The global market for liquid biopsy ... $394.1 million in 2016.  Although in early stages, the ... in particular as a result of the gradual shift ... recent introduction of a significant number of new liquid ... of tumor biomarkers to guide treatment decisions. ...
(Date:7/11/2017)... July 11, 2017 Oramed Pharmaceuticals Inc. (NASDAQ: ... pharmaceutical company focused on the development of oral drug ... Drug Administration (FDA) has agreed to schedule an End-of-Phase ... IIb trial of its oral insulin capsule ORMD-0801 in ... trial met primary and secondary endpoints by indicating a ...
Breaking Medicine Technology: